Literature DB >> 3010968

A possible requirement for arachidonic acid lipoxygenation in the mechanism of phagocytic degranulation by human neutrophils stimulated with aggregated immunoglobulin G.

R J Smith, F S Yein, S C Speziale, B J Bowman.   

Abstract

Aggregated immunoglobulin G (AggIgG) caused a concentration-dependent extracellular release of granule-associated lysozyme and myeloperoxidase (MPO) from human neutrophils. Generation of the 5-lipoxygenase product of arachidonic acid (AA) metabolism, 5(S),12(R)-dihydroxy-6,14-cis,8,10-trans-eicosatetraenoic acid [leukotriene B4 (LTB4)], by neutrophils is exposed to AggIgG occurred in the presence but not absence of exogenous AA. U-60,257B (piriprost potassium), an inhibitor of leukotriene synthesis, caused a dose-related suppression of LTB4 production and granule exocytosis by AggIgG-treated cells. These data suggest that a lipoxygenase product of AA metabolism may mediate AggIgG-induced phagocytic release of granule constituents from neutrophils.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3010968     DOI: 10.1016/0006-291x(86)90911-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  E-type prostaglandins but not iloprost inhibit platelet activating factor-induced generation of leukotriene B4 by human polymorphonuclear leukocytes.

Authors:  P Ney; K Schrör
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. Oxford, 9th-11th September 1987. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1987-12       Impact factor: 8.739

3.  Human polymorphonuclear neutrophil activation with arachidonic acid.

Authors:  R J Smith; L M Sam; J M Justen; K L Leach; D E Epps
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

4.  Release of leukotriene B4 from human neutrophils after interaction with nontypeable Haemophilus influenzae.

Authors:  R Garofalo; H Faden; S Sharma; P L Ogra
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.